Related Experiment Videos
[Mastocytosis in childhood]
Joanna Renke1, Magdalena Lange
1Klinika Pediatrii, Gastroenterologii i Onkologii, Dzieciecej Akademii Medycznej w Gdańsku. jrenke@amg.gda.pl
Przeglad Lekarski
|January 6, 2007
Summary
Mastocytosis is a rare disorder characterized by mast cell overproduction and accumulation. Increased awareness may lead to earlier diagnosis and better management of this multi-symptomatic condition.
Area of Science:
- Hematology
- Dermatology
- Rare Diseases
Background:
- Mastocytosis is a rare disorder involving mast cell accumulation in various tissues, primarily skin.
- Symptoms arise from mediator release or organ involvement.
- While rare overall, it's more common in pediatric dermatology patients.
Purpose of the Study:
- To highlight the prevalence and characteristics of mastocytosis.
- To emphasize the need for increased awareness and diagnosis.
Main Methods:
- Literature review and synthesis of existing data on mastocytosis.
- Analysis of prevalence in pediatric dermatology settings.
Main Results:
- Mastocytosis involves mast cell overproduction and accumulation, most commonly in the skin.
- Prevalence in pediatric dermatology is approximately 5.4 cases per 1000 patients.
- Current treatment options are limited.
Conclusions:
- Mastocytosis presents with diverse symptoms due to mast cell mediators or organ effects.
- Enhanced disease popularization can improve diagnosis and understanding.
- Further research into effective treatments is warranted.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...